AbbVie Inc. (NEO:ABBV)
Canada
· Delayed Price · Currency is CAD 29.53
+0.11 (0.37%)
Apr 3, 2025, 9:30 AM EST
AbbVie Revenue
In the year 2024, AbbVie had annual revenue of $56.33B USD with 3.71% growth. AbbVie had revenue of $15.10B in the quarter ending December 31, 2024, with 5.60% growth.
Revenue
$56.33B
Revenue Growth
+3.71%
P/S Ratio
n/a
Revenue / Employee
$1.02M
Employees
55,000
Market Cap
500.86B CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| WELL Health Technologies | 957.69M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 169.23M |
| Curaleaf Holdings | 1.93B |